Germany: MediCrops consolidates medical cannabis position in Europe with Swiss Alpinopharma  

Ivan Mestrangelo, chair MediCrops

Health tech company MediCrops Holding has acquired Berlin-based Swiss Alpinopharma, a disruptive company in medical cannabis and owner of telemedicine platform Enmedify. Swiss Alpinopharma also offers doctors-certified CME training on the use of medical cannabis. Swiss Alpinopharma is the first and only Swiss company to have successfully launched medicines in Germany, which is the largest…

You must be a HMI Subscriber to view this content.

Subscribe Now »